Loading...
Market
Eli Lilly Increases Production Capacity for Diabetes and Obesity Medicines by End of 2026?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Eli Lilly's production reports or official statements
Story
Eli Lilly Boosts Wisconsin Plant with $3B Investment, Adding 750 Jobs
Dec 5, 2024, 08:33 PM
Eli Lilly and Co. has announced a significant investment of $3 billion to expand its manufacturing facility in Pleasant Prairie, Wisconsin. The expansion aims to increase production capacity for diabetes and obesity medicines, responding to the soaring demand for these treatments. This move is part of a broader $23 billion investment in global manufacturing since 2020. The expansion is expected to create 750 new jobs and will benefit millions of patients globally by enhancing the supply of Lilly's weight-loss and diabetes drugs.
View original story
Similar markets
Increase by more than 50% • 25%
Increase by 30-50% • 25%
Increase by 10-30% • 25%
Increase by less than 10% • 25%
Yes • 50%
No • 50%
3 or more • 25%
2 • 25%
1 • 25%
None • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change or decrease • 25%